Delivery Order SPE2DB22D2206-SPE2DB25FHL37
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $1,226.40. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a single...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $7,523.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This competitively awarded, non-set-aside contract represents a single delivery order fulfillment with an ultimate completion date of September 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a $3,298.53 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $36,036 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pens. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of September 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract executed under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,044.08 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL quantity). The contract, which is not set-aside, is scheduled for completion by June 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $11,940.80 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a $3,798.84 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens. This firm fixed price contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025. As a child contract under...
- The Defense Logistics Agency awarded a $36.6K delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 27, 2025, with completion targeted for August 28, 2025. This is a firm fixed-price, non-competitive set-aside delivery order performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's substantial indefinite delivery contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $1,156.60 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with a completion date of September 8, 2025. This is a firm fixed-price, non-competitive delivery order placed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at approximately $1 billion and extending through December 2026. The contract is being performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with a ceiling value of $1,735.26. This firm fixed-price delivery order, which must be completed by August 11, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement. The contract carries no set-aside designation, indicating it was competitively awarded....
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FHL37Delivery Order
The Defense Logistics Agency awarded a $13,692.03 delivery order to AmerisourceBergen Drug Corp on June 13, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion pharmaceutical supply vehicle running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's DLA Troop Support Medical IDC enables it to supply a diverse range of pharmaceutical products, medical devices, vaccines, and specialty medications to support Defense Health Agency operations and other government healthcare systems worldwide. This particular delivery order for Trulicity, a diabetes medication, exemplifies the company's extensive portfolio of brand-name pharmaceuticals delivered through competitively awarded contracts across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.7k | 6/13/25 |